Aehr Test Systems
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -32.4% | +207.5% | +0.2% | -31.2% | -3.4% | +5.3% | +187.7% | +57.5% | +30.3% | +16.1% | +66.1% | |
| – | -38.8% | +235.8% | +0.3% | -32.0% | -11.9% | +8.7% | +212.8% | +48.4% | +9.9% | -9.3% | +107.8% | |
| – | -83.0% | +1,796.0% | -5.4% | -67.8% | +0.1% | -15.7% | +587.1% | -4.5% | +63.6% | -48.7% | +361.2% | |
| – | -83.0% | +1,796.0% | -5.4% | -67.8% | +0.1% | -15.7% | +587.1% | +52.2% | +2.6% | -48.7% | +361.2% | |
| – | -62.3% | +668.2% | -28.8% | +70.1% | -23.5% | +40.0% | +147.2% | +29.0% | -39.8% | +78.0% | -1.8% | |
| – | -1.3% | -6.1% | +37.0% | +0.1% | -11.8% | +10.8% | +70.1% | +58.8% | +56.7% | +12.1% | -1.5% | |
| – | +151.9% | +17.9% | -15.2% | -13.1% | +165.1% | -17.6% | -7.1% | +319.0% | +1.2% | +106.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | -11.4% | |
| – | +4.4% | +30.9% | -17.2% | -49.8% | +11.3% | +56.7% | +11.0% | +98.8% | -27.6% | +57.1% | +6.0% | |
| – | -28.2% | +68.5% | +41.4% | -50.6% | -29.9% | +134.4% | +21.6% | +48.1% | -35.6% | +48.8% | +14.2% | |
| – | -37.6% | +9.5% | +8,755.1% | – | – | +191.1% | -79.2% | -82.7% | +239.4% | +95.5% | -31.1% | |
| – | +95.2% | +98.7% | -37.3% | +9.7% | -51.1% | +206.1% | +45.0% | +119.5% | -42.1% | +26.2% | +0.4% | |
| – | +57.3% | +2.5% | -100.0% | – | – | -100.0% | – | – | – | – | – | |
| – | -115.9% | – | +15.0% | -19.9% | -9.0% | -18.7% | +345.4% | +48.3% | +47.6% | +10.1% | +78.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.7% | +24.3% | +40.1% | -1.7% | +2.2% | +2.5% | +18.4% | +5.2% | +1.4% | -0.1% | +3.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.